Enavate科学
阶段
Unattributed |活着总了
300美元最后提出了
300美元 | 1年之前缺失:Enavate科学的产品演示和案例研究
促进你的产品提供技术买家。
达到1000年代的买家使用CB的见解来确定供应商,演示产品,德赢体育vwin官方网站做出购买决定。
缺失:Enavate科学的产品&微分器
不要让你的产品被跳过。买家使用我们的供应商排名名单公司和驱动(rfp)请求建议。
最新的Enavate科学新闻
2022年11月10日,
分享这篇文章提供的新闻分享本文门洛帕克,加利福尼亚州,11月10日,2022年Enavate科学,从病人广场资本的投资组合公司,高兴地宣布,h·爱德华·弗莱明(Edd), Jr,医学博士已经加入了该公司执行副总裁,商业化。弗莱明博士James Boylan报告的首席执行官Enavate科学,并将增强Enavate的能力在起源,尽职调查,和谈判的投资机会和支持Enavate合伙人的公司特别关注产品的临床开发和商业评估和投资水平。弗莱明博士是麦肯锡公司高级合伙人,他是一个领袖在其生命科学实践。他建议高管和董事会制药和生物技术公司的核心战略主题,包括研发、投资组合优先级,和商业&报销策略,以及业务发展和并购交易。他是麦肯锡的研发实践的全球领袖在过去的8年,导致公司在客户服务的努力研发机构和研发知识的发展。“我很高兴欢迎Edd Enavate科学和期待他的领导下我们执行我们的战略是一个创新的生物技术公司的首选合作伙伴,努力改变病人的治疗,提高生活质量,“Boylan先生说。“Edd带来财富的关系、经验和判断Enavate科学将极大地有利于我们的合作伙伴公司建立他们的业务通过资本形成,临床开发,商业化,和战略上的考虑。”"I am thrilled to join Enavate Sciences to help build a business that will enable innovative biotech companies to advance important therapies and improve patients' lives," added Dr. Fleming. "As a portfolio company of Patient Square Capital, I believe Enavate Sciences is well positioned to partner with the most promising biotech companies." Dr. Fleming earned his BA in Chemistry from Harvard, his MD from Vanderbilt University, and completed internal medicine training at Johns Hopkins Hospital and subspecialty training in pulmonary and critical care medicine at the University of California, San Francisco. He serves on the Boards of CRISPR Therapeutics, Komodo Health, and Egnite Health and the Board of Visitors for Vanderbilt School of Basic Sciences. About Enavate Sciences Enavate Sciences is a portfolio company of Patient Square Capital dedicated to supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient need. Through the application of capital support and operational experience, Enavate strives to enable and empower a diverse portfolio of therapeutics companies to accelerate innovation. To learn more about Enavate, please visit www.enavatesciences.com . About Patient Square Capital Patient Square Capital ( www.patientsquarecapital.com ) is a dedicated health care investment firm that partners with best-in-class management teams whose products, services and technologies improve health. Patient Square utilizes deep industry expertise, a broad network of relationships and a true partnership approach to make investments in companies grow and thrive. Patient Square invests in businesses that strive to improve patient lives, strengthen communities and create a healthier world. Patient Square's team of industry-leading executives is differentiated by the depth of focus in health care, the breadth of health care investing experience, and the network it can activate to drive differentiated outcomes. Media Contact:
Enavate科学常见问题(FAQ)
Enavate科学的最新一轮融资是什么?
Unattributed Enavate科学的最新一轮融资。
Enavate科学筹集了多少钱?
Enavate科学筹集了总计300美元。
Enavate科学的投资者是谁?
投资者Enavate科学包括病人广场资本。
发现正确的解决方案为您的团队
CB见解德赢体育vwin官方网站科技市场情报平台分析数百万数据点在供应商、产品、合作关系,专利来帮助您的团队发现他们的下一个技术解决方案。